PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
5.62%
Some net income increase while TRVN is negative at -42.47%. John Neff would see a short-term edge over the struggling competitor.
3.20%
Some D&A expansion while TRVN is negative at -1.85%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
No Data
No Data available this quarter, please select a different quarter.
22.07%
SBC growth well above TRVN's 6.39%. Michael Burry would flag major dilution risk vs. competitor’s approach.
81.65%
Well above TRVN's 117.63% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
50.82%
Lower AP growth vs. TRVN's 146.79%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
28.44%
Some yoy usage while TRVN is negative at -99.77%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-17.77%
Negative yoy while TRVN is 4.12%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
18.75%
Operating cash flow growth 1.25-1.5x TRVN's 16.62%. Bruce Berkowitz might see better working capital management or consistent margin advantages.
-1425.00%
Negative yoy CapEx while TRVN is 0.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1425.00%
We reduce yoy invests while TRVN stands at 10.10%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-0.29%
Negative yoy issuance while TRVN is 84.67%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.